New class of generics could save consumers, insurers billions. FDA is moving carefully.

Jul 13, 2016
The European Union has some 20 "biosimilar" generics on the market; the US has one.
Pre-filled syringes of  the adalimumab biosimilar.  The biosimilar is used in the treatment of rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis and ankylosing spondylitis.
SAM PANTHAKY/AFP/Getty Images

FDA says it's time to look again at food labeling claims

May 10, 2016
Reevaluating dietary guidelines to help consumers decide what's healthy
Kind bars were the subject of discussion recently when it came down to the semantics of what can be labeled as "healthy" per FDA rules. 
John Parra/Getty Images for SOBEWFF®

How the new e-cigarette regulations will impact small businesses

May 5, 2016
Small shops and vape-makers worry the regulation will put them out of business.
The FDA's new regulations on tobacco includes e-cigarettes, which may impact the industry.
FRANCK FIFE/AFP/Getty Images

FDA takes step to improve generic drug competition

Mar 15, 2016
We'd pay a lot more if it wasn’t for generics, which amount to as much as 85% of what we take.
Joe Raedle/Getty Images

How more generics could relieve sky-high drug prices

Feb 4, 2016
More generics are needed to create competition — but can the FDA approve them fast enough?
With high drug prices, more generics are needed to create competition, but can the FDA is having a hard time keeping up.
NVinacco/Flickr

For public good, not for profit.

New cholesterol drugs shed light on pricing conundrum

Dec 29, 2015
Earlier this year, the FDA approved applications from Sanofi and Amgen.

Salmon first GMO animal OK'd for sale

Nov 23, 2015
A Massachusetts bio-agriculture firm can now market its fast-growing GMO salmon, without special labeling.